About this trial
The goal of this clinical trial is to investigate the efficacy of mesotherapy in patients with lateral epicondylitis and to determine whether it is as effective as extracorporeal shock wave therapy (ESWT).
Is mesotherapy an effective method in patients with lateral epicondylitis?
Researchers will compare Mesotherapy to extracorporeal shock wave therapy (ESWT) in patient with Lateral epicondylitis.
Patients will be randomly assigned to either the Mesotherapy group or the ESWT group using a closed envelope method.
* Group 1 (Mesotherapy group): Patients will receive a total of 5 sessions of mesotherapy, with one session every 7 days. * Group 2 (ESWT group): Patients will receive a total of 5 sessions of Extracorporeal Shock Wave Therapy (ESWT), with one session every 7 days.
Patients will be assessed at three time points: before treatment, 30 minutes after the completion of the treatment, and 12 weeks after the completion of the treatment
Eligibility criteria
Qualifiers
Aged between 18 and 65 years
Pain and tenderness in the unilateral lateral epicondyle for ≥6 weeks
Clinically diagnosed with Lateral Epicondylitis
Patients without cognitive deficits who can follow verbal instructions
Disqualifiers
Receiving an interventional injection in the elbow region within the last 3 months
Receiving physical therapy in the last 3 months
Receiving regular nonsteroidal anti-inflammatory drug (NSAID) treatment in the last 2 weeks
History of fracture or surgery in the affected elbow region
Trial design
Treatments tested in this trial
- Extracorporeal Shock Wave Therapy
- Mesotherapy